Featured Story

ForSight Vision5 ropes in $15M in Series C financing to develop its intraocular therapy

ForSight Vision5 raised $15 million in a Series C financing and completed enrollment of a Phase II clinical study to support the development of its noninvasive ocular implant therapy for eye diseases.


Abbott's device sales slip as diagnostics keeps revenue rolling

Abbott Laboratories posted another quarterly decline in medical device revenue, but its fast-growing diagnostics business came through yet again.

TriVascular pockets $78M in a scaled-down IPO

Medical device outfit TriVascular Technologies picked up $78 million as it made its Wall Street debut Wednesday, pricing below its expected range amid a prolonged slump for life sciences stocks.

Cardiac Dimensions raises $20M for heart valve expansion in Europe, Australia


Cardiac Dimensions, a privately held medical device company focused on mitral valve repair, raised $20 million in a new round of private equity financing to support expansion in European and Austrailain markets.


Qiagen puts up $10M to boost its diagnostics manufacturing

Molecular diagnostics company Qiagen will invest $10 million to build out manufacturing capabilities at its Germantown, MD, campus by early 2015, focusing on products for women's health and infectious disease.